This CEU course delves into the intricate landscape of depression, emphasizing the nuances of recognition and understanding of treatment resistance. The course will explore various therapeutic modalities and interventions tailored to address treatment-resistant depression, providing valuable insights for clinicians seeking to enhance their practice in mental health care.

Dr. Cusin is the director and founder of the Massachusetts General Hospital  Ketamine clinic for treatment-resistant depression. She also has an outpatient clinic at the hospital's Depression Clinical and Research Program and often performs consultations for patients with Treatment-Resistant Depression. She has expertise in ketamine, VNS and DBS. Finally, she is one of the clinicians in the ECT team at MGH and she is involved in numerous research studies on ketamine in treatment-resistant mood disorders at MGH.